Girshick Birgit's Form 4 filing
Charles River Laboratories International, Inc. (CRL) · filed Sep 15, 2021
- Accession no.
- 0001127602-21-025281
- Filed
- Sep 15, 2021
- Trade date
- Sep 13-14, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.07M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Girshick BirgitCIK 0001732091 | Officer (Corporate Executive VP) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Common Stock | SSaleDisposed | −2 | $441.66 | −$883.32 | 30,025 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −72 | $442.15 | −$31,834.8 | 29,953 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −7 | $442.73 | −$3,099.11 | 29,946 | Direct | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −2,344 | $439.90 | −$1,031,125.6 | 27,602 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.